Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

30.06USD
8:59pm GMT
Change (% chg)

$-0.21 (-0.69%)
Prev Close
$30.27
Open
$30.39
Day's High
$30.54
Day's Low
$29.52
Volume
47,976
Avg. Vol
86,863
52-wk High
$40.60
52-wk Low
$15.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 19.24 -0.729
Jun '18 18.32 -0.754
Mar '18 17.11 -0.445
FY 2017 Dec '17 18.04 -0.349
Sep '17 9.91 -0.330
Jun '17 5.71 -0.705
Mar '17 6.09 -2.211
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 86.53 172.30 24.70 --
Quarter Ending Jun-19 4 110.30 203.50 29.70 --
Year Ending Dec-19 5 369.92 819.00 148.40 302.27
Earnings (per share)
Quarter Ending Mar-19 4 -0.31 0.16 -0.69 --
Quarter Ending Jun-19 4 0.25 2.25 -0.71 --
Year Ending Dec-19 4 -0.19 5.88 -2.48 0.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.71
P/E High - Last 5 Yrs. -- 45.02 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta -- 0.90 0.90
Price to Sales (TTM) 78.42 4.12 6.28
Price to Book (MRQ) -- 5.11 5.27
Price to Tangible Book (MRQ) -- 5.85 6.79
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 10.29 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.30 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 4.14 5.87
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 12.27 45.04 47.26
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.26
Current Ratio (MRQ) 1.78 2.98 3.08
LT Debt to Equity (MRQ) -- 8.86 11.38
Total Debt to Equity (MRQ) -- 12.90 16.13
Interest Coverage (TTM) -- 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -142.68 53.65 53.78
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -525.72 -- --
EBITD - 5 Yr. Avg -- 17.95 12.87
Operating Margin (TTM) -526.50 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.31
Pre-Tax Margin (TTM) -530.85 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.61
Net Profit Margin (TTM) -530.85 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.88
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 912,500 959,798,954 844,239,694
Net Income/Employee (TTM) -4,843,962 113,819,313 100,064,161
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) -- 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -- 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -- 16.31 15.99
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -35.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akcea Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 28.43 24.01 99 22
13 Week -- -- -- 39
26 Week -- -- -- 33
52 Week -- -- -- 9
YTD -- -- -- 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.36%
# of Holders: 109
Total Shares Held: 23,524,891
3 Mo. Net Change: 3,795
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 8
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.